2-Bromo-5-Phenylthiazole

2-Bromo-5-phenylthiazole (CAS 1072-45-5, C₉H₆BrNS, molecular weight 240.12 g/mol) is commercially supplied as a pale yellow crystalline solid with a melting range of 58–60 °C. The compound is frequently catalogued under product codes such as B25505, BB0266, or equivalent, and is typically offered in unit sizes of 1 g, 5 g, and 25 g with a certified purity of ≥98% by GC area normalization. The molecule consists of a thiazole ring brominated exclusively at the 2-position and substituted with a phenyl group at the 5-position, a substitution pattern that renders the C–Br bond significantly more electrophilic than its 4‑bromo or 5‑bromo regioisomers. In pilot‑scale preparations performed in 5 L jacketed glass reactors under nitrogen sparging, batch-to-batch variations in colour from near‑white to faint yellow have been observed when the recrystallisation solvent (typically ethanol/water mixtures) deviates by more than ±5 % water content; this does not impact the GC purity but can alter the UV‑cutoff in subsequent photochemical applications.

Regioisomeric Reactivity Drives Synthetic Strategy

The 2‑bromo substituent sits adjacent to the ring nitrogen, an arrangement that lowers the LUMO energy of the thiazole and accelerates oxidative addition with Pd⁰ relative to the 4‑bromo analogue. 4‑Bromo-5‑phenylthiazole (CAS 1072-45-4, melting range 68–70 °C) requires approximately 1.5–2× the catalyst loading to achieve comparable conversion in Suzuki couplings, and its slower insertion kinetics often mandate reaction temperatures of 90–95 °C rather than the 75–85 °C range sufficient for the 2‑bromo isomer. Furthermore, the 2‑bromo compound shows markedly different behaviour in nucleophilic aromatic substitution: primary amines displace the bromine smoothly at ambient temperature to form 2‑aminothiazole derivatives, whereas the 4‑bromo isomer remains inert under the same conditions. This dichotomy is exploited when a phenylthiazole scaffold needs to be elaborated orthogonally—site‑selective C–N bond formation at position 2 followed by a metal‑catalysed coupling at position 4, for example—without the steric congestion that would accompany a 2,4‑dibromo intermediate.

What Conditions Maximize Yield in Suzuki-Miyaura Couplings?

Standard Pd(PPh₃)₄ catalysis (1 mol%) with 2 equivalents of K₂CO₃ in a degassed DME/water (4:1 v/v) medium converts 2‑bromo‑5‑phenylthiazole to its biaryl products within 2–4 hours at 80 °C. When electron‑rich arylboronic acids are employed, switching the ligand to SPhos (2 mol%) and the base to K₃PO₄ (ground to a fine powder, 3 equivalents) suppresses proto‑dehalogenation, a side reaction that can consume up to 15% of the starting bromide if the reaction mixture is not thoroughly deoxygenated. In the absence of rigorous freeze‑pump‑thaw cycling, a continuous nitrogen flow through the condenser and a subsurface sparge for 20 min prior to catalyst addition reduces the oxygen level below the detection limit of a dissolved‑oxygen probe (≤0.1 mg/L) and restores the isolated yield to the 85–92% bracket. The processing window is narrow when the arylboronic acid carries an ester functionality: prolonged heating above 85 °C initiates saponification, and the resultant carboxylate poisons the palladium centre. Operators running 500 g batches in a 10 L cylindrical reactor equipped with a pitched‑blade turbine have found that limiting the heating mantle set‑point to 82 °C and terminating the reaction as soon as HPLC analysis (C18 column, 254 nm detection) indicates <1% remaining starting material curtails the hydrolysis cascade. When executing multi‑gram couplings of 2‑bromo‑5‑phenylthiazole with electron‑deficient arylboronic acids, the addition of 2‑dicyclohexylphosphino‑2′,6′‑dimethoxybiphenyl (SPhos) as a ligand has been observed to maintain catalytic activity beyond 5 hours, whereas the triphenylphosphine‑based system begins to form palladium black after 3 hours. ICP‑MS analysis of the filtered crude reaction mixture after a 6‑hour run revealed residual palladium levels of 12 ppm with the SPhos protocol, compared to 45 ppm with PPh₃—a critical distinction when the biaryl product is destined for in‑vivo pharmacological evaluation. To further reduce metal contamination, a post‑reaction treatment with activated carbon (Darco G‑60, 10 wt% relative to product) stirred at 60 °C for 1 hour drops the palladium content below the 5‑ppm threshold imposed by the ICH Q3D guideline for parenteral products.

Analytical Specifications and Storage Protocol

Parameter	Method	Specification
Purity	GC (FID, HP‑5 column, 30 m × 0.25 mm, film 0.25 µm)	≥98.0% area
Melting range	DSC, heating rate 10 °C/min under N₂	58–60 °C
Water content	Karl Fischer coulometry (ISO 760)	≤0.5%
Appearance	Visual inspection	Pale yellow crystalline solid
Storage temperature	Stability chamber monitored per ICH Q1A	+2 to +8 °C
Packaging atmosphere	Head‑space GC	Argon, residual oxygen <0.2%

The compound shows no hygroscopicity at 25 °C/60% RH (dynamic vapour sorption, ≤0.1% mass increase after 24 h), so pre‑drying is not necessary when the material has been stored under argon. However, if the container has been repeatedly opened under ambient humidity, vacuum drying over P₂O₅ (0.1 mbar, 24 h) restores the water content below 0.1%. Prolonged exposure to direct sunlight or fluorescent laboratory lighting induces a surface‑darkening effect; testing in an Atlas Suntest CPS+ apparatus (xenon arc, 300–800 nm, irradiance 550 W/m²) showed 0.3% degradation after 48 h, which exceeds the recommended limit for active pharmaceutical ingredient intermediates. Therefore, amber borosilicate vials are specified for all quantities above 1 g.

When the 2‑Chloro Analog Fails to Meet Coupling Timelines

The 2‑chloro derivative (CAS 1072-44-3) is often selected for its lower raw‑material cost, but the gain is quickly offset by the substantially longer reaction times and higher catalyst consumption. Under the identical Suzuki protocol described above, 2‑chloro‑5‑phenylthiazole reaches 90% conversion only after 18–24 h at 100 °C and demands a catalyst loading of 3 mol% Pd(OAc)₂ plus 6 mol% of a bulky phosphine ligand. This slower oxidative addition stems from the higher bond dissociation energy of the C–Cl bond (estimated 95–100 kcal/mol vs. 72–78 kcal/mol for C–Br). The iodo analogue (CAS 1072-46-6) reacts even faster—complete conversion within 30 min at 60 °C—but suffers from an acute sensitivity to ambient light that generates iodine and promotes radical side reactions, necessitating handling under red‑filtered safety lights. The table below summarises the practical trade‑offs for a representative Suzuki coupling with phenylboronic acid.

Halide	Relative oxidative addition rate (estimated)	Typical reaction time	Temperature	Approx. relative raw‑material cost
2‑Iodo	10–15	0.5 h	60 °C	4–5×
2‑Bromo	1.0 (reference)	2–4 h	80 °C	1.0×
2‑Chloro	0.03–0.05	18–24 h	100 °C	0.6–0.7×

Published comparative data for these exact substrates under strictly identical conditions are limited; the trends reported here align with the well‑established reactivity series for heteroaryl halides, where the bromo congener provides the most favourable balance of throughput, selectivity, and operational convenience. For discovery chemistry groups that synthesize 50–200 biaryl analogues per week, the 2–4 h cycle time achievable with 2‑bromo‑5‑phenylthiazole fits comfortably within a single work shift, whereas the chloro analogue would require an overnight run with mandatory re‑flush of the inert atmosphere to prevent catalyst deactivation. In scaffold diversification programmes that demand sequential cross‑couplings, the monobrominated 2‑bromo‑5‑phenylthiazole presents an unambiguous reactive handle that avoids the chemoselectivity puzzles introduced by 2,5‑dibromo‑ or 2,4‑dibromothiazole building blocks. Competing oxidative addition at two sites in a polyhalogenated substrate inevitably produces statistical mixtures unless one halide is substantially more activated—a condition that rarely translates cleanly across a range of boronic acids. With the single 2‑bromo moiety, the first coupling installs an aryl or heteroaryl group at position 2, after which the remaining thiazole C–H bonds can be functionalised via directed C–H activation or through the introduction of a second halogen using a mild electrophilic reagent such as N‑bromosuccinimide in DMF at 0 °C. This stepwise logic has been scaled to 100 g batches in a 2 L double‑jacketed vessel without incident, the intermediate di‑substituted thiazole being isolated by simple filtration after addition of water, with a purity of >95% by qNMR using 1,3,5‑trimethoxybenzene as an internal standard. The absence of an extraneous halogen eliminates the requirement for high‑resolution chromatographic separation of regioisomeric by‑products, trimming purification costs by an estimated 30–40% relative to routes that start from the dibromo precursor.